MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Communicable Diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Communicable Disease Control < Communicable Diseases < Community Health Services  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000857 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
000A23 (2017) Stefan Rose-John [Allemagne] ; Kevin Winthrop [États-Unis] ; Leonard Calabrese [États-Unis]The role of IL-6 in host defence against infections: immunobiology and clinical implications.
001010 (2015) Vibeke Strand [États-Unis] ; Sima Ahadieh [États-Unis] ; Jonathan French [États-Unis] ; Jamie Geier [États-Unis] ; Sriram Krishnaswami [États-Unis] ; Sujatha Menon [États-Unis] ; Tina Checchio [États-Unis] ; Thomas G. Tensfeldt [États-Unis] ; Elaine Hoffman [États-Unis] ; Richard Riese [États-Unis] ; Mary Boy [États-Unis] ; Juan J. G Mez-Reino [Espagne]Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials.
001462 (2013) James E. Frampton [Oman]Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.
001802 (2012) Andrea Rubbert-Roth [Allemagne]Assessing the safety of biologic agents in patients with rheumatoid arthritis.
001A57 (2009) Masahiro Murayama[Proper usage of biologics for treatment of rheumatoid arthritis].
001C30 (2004) M. Bayes [Espagne] ; X. Rabasseda ; J R ProusGateways to clinical trials.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Communicable Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Communicable Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Communicable Diseases
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021